NPDPSC Leadership & Advisory Board

Name	Position	Role
Brian Appleby, MD	Director	General oversight of NPDPSC. Clinical follow-up and diagnostics for human prion cases. Maintain relationships with caregivers, patient families, state public health departments, CDC, and the CJD Foundation.
Mark Cohen, MD	Co-Director, Histology Section Director	Clinical neuropathology – histopathological and immunohistochemical diagnostics.
Shashi Shetty, PhD, FACMG	Genetics & CLIA Lab Director, Molecular Section Director	Prion diagnostics laboratory oversight, as well as genetics and molecular specialist.
Allison Kraus, PhD	Associate Director	Development of prion protein seeding assays and improved diagnostics.
Qingzhong Kong, PhD	Associate Director	Molecular analyses of prions and development of prion disease diagnostics.
Ignazio Cali, PhD	Associate Director	Molecular characterization and Neuropathology – histopathological and immunohistochemical diagnostics.

Advisory Board - The following members are part of the Center's advisory board, who provide support and advise the members of the faculty (listed above).

**Note - advisory board members do not work for and are not personnel of the Center.

Name	Role
Clifford Harding, MD, PhD	Professor and Chair of Pathology, Department of Pathology, School of Medicine, CWRU.
William P. Schiemann, PhD	Vice Dean for Research, School of Medicine, CWRU.
Jonathan Haines, PhD	Chair of Department of Population and Quantitative Health Sciences, School of Medicine, CWRU.
Ms. Debbie Yobs	President of CJD Foundation.
Bernardino Ghetti, MD	Distinguished Professor of Pathology, Indiana University School of Medicine.
Richard Knight, MD	Emeritus Professor of Clinical Neurology, University of Edinburgh, National CJD Research and Surveillance Unit